Leaderboard

En | De
No articles selected!     View Cart  
You are here: Urology-Nephrology » Neoplasia/BPH 15. October 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Zoom: Zoom In Zoom Out

   Page 1 of 9602  Previews Next
   
   Articles 1 - 20 / 192038  
   
Aberrant HER2 Expression as a Specific and Feasible Diagnostic Marker for Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Hum Pathol
Hu J, Zhang M, Meng L, Zheng L, Yang Y, Tang J, Pan X, Yin X, Yu T, Nie L, Wei Y, Zhou Q, Chen X, Chen N.
PMID: 42874879 [PubMed - as supplied by publisher]


Periprostatic adipose tissue imaging in prostate cancer: Imaging phenotypes, task-specific spatial strategies, and multicompartment integration-a critical review.
Eur J Radiol
Huang J, Zhang Y, Yang O, Feng Q, Du H, Gong J, Huang G.
PMID: 42874220 [PubMed - as supplied by publisher]


PANoptosis-Related Molecular Subtyping and a Subtype-Derived Prognostic Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma.
Technol Cancer Res Treat
Wang X, Shen Y, Du S, Wang H, Xie X, He H.
PMID: 42874083 [PubMed - indexed for MEDLINE]


Dose-Escalated Focal Salvage High-Dose-Rate Brachytherapy and Genomic Classifier Risk Stratification in Radiorecurrent Prostate Cancer: The F-SHARP Phase I/II Clinical Trial.
J Clin Oncol
Solanki AA, Adams W, Proudfoot JA, Baldea K, Barkan GA, Block AM, Desai NB, Farooq A, Folkert MR, Garant A, Gorbonos A, Gupta G, Kang H, Kelly E, Kregel S, Liauw SL, Luminais CK, Mysz M, Quek ML, Showalter TN, Welsh JS, Woods M, Davicioni E, Small W Jr, Harkenrider MM.
PMID: 42874014 [PubMed - as supplied by publisher]


Educational disparities in prostate cancer survival: a retrospective cohort study from Mexico City.
Salud Publica Mex
Hernández-Pérez JG, Reyes-Morales H, Valenzuela-Sánchez A, Lajous M, Rodríguez-Covarrubias F, Espin-Arellano LI, Morales-Carmona E, Manzanilla-García H, Torres-Sánchez LE.
PMID: 42873951 [PubMed - indexed for MEDLINE]


Dehydrated human amniotic membrane for early return of erectile function after robotic radical prostatectomy: a 10-year journey and lessons learned.
J Robot Surg
Razdan S, Fathollahi A, Armache A, Razdan S.
PMID: 42873363 [PubMed - indexed for MEDLINE]


Skin-Related Adverse Events in Patients Treated With Apalutamide Versus Enzalutamide for Prostate Cancer: A Japanese Real-World Database Study (A Retrospective Cohort Study).
Health Sci Rep
Hashizume A, Kawahara T, Yamazaki M, Takamoto D, Takeshima T, Kuroda S, Uemura H, Makiyama K, Teranishi JI.
PMID: 42871337 [PubMed]


Omission of lateral isocenter shifts in robust optimization of proton therapy treatment plans for prostate cancer.
J Appl Clin Med Phys
O'Grady FT, Castro J, Kim DW, Fan J, Wang P.
PMID: 42870582 [PubMed - indexed for MEDLINE]


Prostate Cancer Therapy via Inhibition of Negative Immune Regulation.
Biomed Res Int
Dutta S, Sengupta P, Chowdhury U, Maldonado Rosas I, Kalita JC, Selvam MKP, Roychoudhury S.
PMID: 42870457 [PubMed - indexed for MEDLINE]


Liquid biopsy in bladder cancer: towards precision oncology.
J Transl Med
Chen C, Yang Y, Chen Z, Li X, Zhu Y, Zhai Y, Zheng J, Dai X, Zhou JG, Ma H, Ye X.
PMID: 42870280 [PubMed - indexed for MEDLINE]


Reproducibility and diagnostic performance of ADC for assessing response to neoadjuvant immunotherapy in muscle-invasive bladder cancer: a multi-ROI comparison analysis from the phase-Ib NABUCCO trial.
Insights Imaging
Greidanus J, Bernabei C, Chupetvloska K, Agrotis G, Mertens LS, van Rhijn BWG, van der Poel HG, van der Heijden MS, Beets-Tan RGH, Pizzi AD, Boellaard TN, Trebeschi S.
PMID: 42870138 [PubMed]


Fracture risk and fracture risk factor assessment among men at prostate cancer diagnosis.
Prostate Cancer Prostatic Dis
Shulman MJ, Darbinian JA, Chandra M, Harzstark AL, Lo JC.
PMID: 42869964 [PubMed - as supplied by publisher]


Contemporary Oncological and Patient-reported Outcomes of Intravesical Gemcitabine/Docetaxel in BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Multi-institutional Prospective Cohort Study.
Eur Urol Focus
Tan YG, Dudinec J, Kamat AM, Lim BJH, Ghoreifi A, Yuen JSP, Chen K, Kanesvaran R, Chan J, Shah AM, Tay KJ, Abern MR.
PMID: 42869744 [PubMed - as supplied by publisher]


Response to "Calendar-time bias in a TriNetX study of GLP-1 receptor agonists, SGLT2 inhibitors and bladder cancer survival".
Urol Oncol
Kohler J, Rodler S.
PMID: 42869700 [PubMed - as supplied by publisher]


Initial complete local therapy without systemic therapy versus systemic-therapy-based management in selected patients with oligometastatic renal cell carcinoma: a matched comparative study.
Radiother Oncol
Kim HU, Lee HI, Park I, Kim JK, Kim YJ.
PMID: 42869248 [PubMed - as supplied by publisher]


Immune Checkpoint Inhibitors in Metastatic Renal Cell Carcinoma With Sarcomatoid Dedifferentiation: A Multicenter Retrospective Study.
J Natl Compr Canc Netw
Gopalakrishnan D, Fujiwara Y, Collier KA, Park JJ, Zaemes JP, Lam ET, Alaklabi S, Jaeger EB, Barata PC, Kauffman EC, Atkins MB, Alva A, Yang Y, George S.
PMID: 42869085 [PubMed - as supplied by publisher]


[Molecular-Based Diagnostics and Therapy of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)].
Aktuelle Urol
Kesch C, Hadaschik B, von Amsberg G.
PMID: 42869040 [PubMed - as supplied by publisher]


Adenoma laterality and risk of subsequent colorectal cancer: Secondary analysis of the Prostate, Lung, Colorectal, and Ovarian Cancer trial.
Surgery
Frebault J, Troester A, Huo L, Rudser K, Hassan I, Shaukat A, Goffredo P.
PMID: 42868921 [PubMed - as supplied by publisher]


Real-World Tumor-Informed Circulating Tumor DNA Dynamics and Survival Associations in Advanced Urothelial Cancer Treated With First-Line Enfortumab Vedotin and Pembrolizumab.
JCO Precis Oncol
Nimgaonkar V, Arbuiso A, Vlachou E, Johnson BA, Smith A, Kates M, Patel S, Singla N, Russell S, Rourke K, Elias R, Matoso A, Baraban EG, Hahn NM, Hoffman-Censits J.
PMID: 42868336 [PubMed - indexed for MEDLINE]


Fracture and Vertebral Augmentation Utilization Following Androgen Deprivation Therapy in Men With Prostate Cancer: A Propensity Score-matched Cohort Study.
Global Spine J
Taka T, Cummings C, Meng S, Miner A, Dietrich G, Shin D, Trivedi T, Goodwin R, Richardson W, Danisa O.
PMID: 42868235 [PubMed - as supplied by publisher]


   
   Articles 1 - 20 / 192038    Page 1 of 9602  Previews Next

 
Rect Bottom
Adserver Footer
 

  Time frame  
   

Sky right 1